US drugmaker Pfizer on Thursday said it has formally requested emergency use authorization for its COVID-19 vaccine in children aged five to 11.
Children have been infected in greater numbers in the latest wave of infections driven by the Delta variant of SARS-CoV-2, and inoculating young people is seen as key to keeping schools open and helping end the COVID-19 pandemic.
In late September, Pfizer and BioNTech, a German firm that codeveloped the vaccine, began submitting data to US Food and Drug Administration (FDA) regulators for the highly anticipated authorization.
Pfizer early on Thursday wrote on Twitter that the two companies had “officially submitted our request” to the FDA “for Emergency Use Authorization (EUA) of our #COVID19 vaccine in children 5 to <12.”
“We’re committed to working with the FDA with the ultimate goal of helping protect children against this serious public health threat,” Pfizer said.
The FDA last week said that it had scheduled a meeting of an advisory committee to review the data on Oct. 26, before giving its opinion on whether authorization should be granted.
The agency has previously said that once the formal submission was completed, it would complete its review “likely in a matter of weeks rather than months.”
The US Centers for Disease Control and Prevention (CDC) would subsequently publish recommendations for use for healthcare providers administering COVID-19 vaccines.
“If there is approval or authorization, and a CDC recommendation, we are ready, we have the supply,” Jeff Zients, an adviser to US President Joe Biden and White House coronavirus response coordinator, told CNN following the announcement. “I think we can all agree that getting a safe and effective vaccine for kids five to 11 is a really important next step in our fight against the virus.”
In clinical trials, children in the five-to-11 age group received a two-dose regimen of 10 micrograms, compared with 30 micrograms for older age groups. The shots were given 21 days apart.
The Pfizer-BioNTech vaccine has been granted full FDA approval for those aged 16 or older, and the FDA in May authorized its emergency use in children aged 12 to 15.
Experts say that children are essential to vaccinate to help achieve population immunity against the disease.
While younger children are less likely to develop severe cases, they can still become sick and transmit the virus to the general population.
“We’re working with states to set up convenient locations for parents and kids to get vaccinated, including pediatricians’ offices and community sites,” Zients said.
As of Thursday last week, nearly 5.9 million US children had tested positive for COVID-19, American Academy of Pediatrics data showed.
Vaccines, masks and other mitigation measures against COVID-19 have become deeply political issues in the US — especially for children.
California last week announced that vaccinations would be compulsory for all students, a first in the US.
About one-third of US parents with a child aged five to 11 say that they would vaccinate their children as soon as possible, a survey conducted by the Kaiser Family Foundation showed last month.
However, one-third say they would wait before making a decision, and one-quarter say they would not get their child vaccinated.
The Pfizer-BioNTech vaccine received full, formal approval in the US in August and is therefore technically available to children in younger age groups if prescribed by a doctor, but US authorities have cautioned against doing this until the safety data was available.
Health officials are focusing in particular on the risk of myocarditis, an inflammation of the heart muscle that has been found to be more common in young adults and adolescents after vaccination, with an aim of determining whether benefits outweigh risks.
Pfizer and BioNTech are also trialing their vaccine on infants aged six months to two years, and on children aged two to five. Initial data for these groups are expected before the end of the year.
Japan’s Mount Aso erupted yesterday, spewing a giant column of ash thousands of meters into the sky as hikers rushed away from the popular tourist spot. No injuries were immediately reported after the late-morning eruption in southwest Japan, which sent rocks flying in a dramatic blast captured by nearby CCTV cameras. People were warned not to approach the volcano as it ejected hot gas and ash as high as 3,500m, and sent stones tumbling down its grassy slopes. Authorities were checking if any hikers had been trapped or injured, officials told local media, as TV footage showed dozens of vehicles and tour buses
South Korea yesterday said that it would lift COVID-19 restrictions on social gatherings next week as the country prepares to switch to a “living with COVID-19” strategy amid rising vaccination levels. A new panel established this week is drawing up a plan for a gradual lifting of curbs, aiming to lift restrictions and reopen the economy next month on the expectation that 80 percent of the adult population will be fully vaccinated. From Monday, the South Korean government is to allow gatherings of up to four unvaccinated people and ease operating-hour restrictions imposed on venues such as restaurants, cafes and cinemas, South
‘AVOIDABLE SITUATION’: After being tortured in his home country, a Sri Lankan and his family are at risk of deportation from the UK, despite his academic fellowship A scientist conducting groundbreaking research into renewable energy is facing deportation with his family to Sri Lanka, where he was tortured, after receiving contradictory information about his case from the British Home Office. Nadarajah Muhunthan, 47, his wife, Sharmila, 42, and their three children, aged 13, nine and five, went to the UK in 2018 after Muhunthan, who is working on thin-film photovoltaic devices used to generate solar power, was given a prestigious Commonwealth Rutherford fellowship. The award allowed him to reside to the UK for two years to research and develop the technology. His wife obtained a job caring for
A top global law firm is no longer representing the University of Hong Kong (HKU) in seeking the removal of a Tiananmen memorial from its campus after it came under heavy criticism in the US for helping China purge dissent, the Washington Post reported. Mayer Brown is the latest international company to face pressure over how its actions in China contradict its more progressive statements in the West. The 8m high Pillar of Shame sculpture by Danish artist Jens Galschiot has stood on HKU’s campus since 1997, the year the city was handed back to China. It features 50 anguished faces and tortured